Opis: | Liječnica |
Izvor: | Disertacija |
Marija Usenovic
Department of Neurology, Massachusetts General Hospital
Harvard Medical School, MassGeneral Institute for Neurodegenerative Disease
1EDUCATION
October 2008-present
Ph.D. in Neuroscience, expected date: November 2012
Research and thesis advisor: Dimitri Krainc, M.D., Ph.D., Massachusetts General Hospital / Harvard Medical School.
Degree granting institution: University of Split, School of Medicine, Croatia
Thesis Title: ˝The role of PARK9 protein in lysosomal degradation pathway in neurodegeneration˝ M.S. in Molecular Biology; 2007
University of Zagreb, Faculty of Natural Sciences, Croatia
WORK EXPERIENCE
October 2008-present
Visiting graduate student; Department of Neurology, Massachusetts General Hospital, Harvard Medical
School, Boston, USA
Mentor: Dimitri Krainc, M.D., Ph.D., Professor of Neurology
Project: ˝Lysosomal degradation pathway in neurodegeneration; the role of PARK9˝
May 2007-October 2008
Research assistant; Mediterranean Institute for Life Sciences, Split, Croatia
Advisors: Dimitri Krainc, M.D., Ph.D. and Janos Terzic M.D., Ph.D.